Keros Therapeutics KROS
NASDAQ KROS
$9.54 +0.21 (+2.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Keros Therapeutics (KROS) Times Interest Earned (2019 - 2022)

Updated

Keros Therapeutics' Times Interest Earned came in at -114790.00 for FY2022, compared with -14093.25 in FY2021.

Analysis

Keros Therapeutics (KROS) Times Interest Earned (2019 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Times Interest Earned at -14093.25 in FY2021 and -7776.17 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Keros Therapeutics 185.02 Mn -900.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -24,126.00
Dec 31, 2021 -4,866.00
Sep 30, 2021 -20,197.00
Jun 30, 2021 -15,541.00
Mar 31, 2021 -15,769.00
Dec 31, 2020 -13,291.00
Sep 30, 2020 -5,974.00
Jun 30, 2020 -10,914.00
Mar 31, 2020 -5,252.00
Sep 30, 2019 -775.33
Jun 30, 2019 -1,325.50
Mar 31, 2019 -1,429.00
API Access

Keros Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=KROS&period=max&api_key=YOUR_API_KEY